Parataxis Capital

Parataxis Capital is a multi-strategy investment firm specializing in the digital asset sector. Founded in 2019, the firm is headquartered in New York City and operates as a Service-Disabled Veteran-Owned Small Business. Parataxis Capital offers a range of investment strategies, including hedge fund vehicles and sub-advisory services, catering to institutional allocators, family offices, fund-of-funds, and high-net-worth individuals. The firm's focus encompasses various digital assets, including cryptocurrencies, blockchain technologies, and other emerging digital financial instruments.

The firm's investment approach is characterized by a combination of traditional financial market expertise and digital asset proficiency, enabling the identification of unique, risk-managed investment opportunities. Parataxis Capital emphasizes disciplined risk management practices and leverages its extensive market access to provide investors with uncorrelated and asymmetric investment exposures. The firm's strategies are designed to adapt to the dynamic and evolving digital asset landscape, aiming to deliver value creation at a significant scale.

Parataxis Capital's portfolio includes investments in companies such as Bridge Biotherapeutics, a clinical-stage biotech firm, and ZTX, a blockchain-based platform. The firm's expansion into South Korea through the acquisition of Bridge Biotherapeutics demonstrates its commitment to global market presence and the integration of digital asset strategies across diverse sectors. Parataxis Capital's track record reflects a focus on delivering bespoke investment exposures that align with the evolving needs of its investors in the digital asset ecosystem.